Securities
Stock Reports
Com2uS Corporation: New Release ZEUS CO., LTD. Exceeds Expectations… Target Price Raised – NH
On the 10th, NH INVESTMENT & SECURITIES significantly raised its earnings estimates for Com2uS Corporation(078340), noting that the company’s new game, “ZEUS CO., LTD.: God of Arrogance,” has been per…
Stock Reports
E-MART Co., Ltd.’s Earnings Trend to Depend on Starbucks Korea for the Time Being… ‘Buy’—IBK
IBK Investment & Securities announced on the 10th that it is maintaining its “Buy” rating and 100,000 won target price for E-MART Co., Ltd.(139480).
Namsung, an analyst at IBK Investment & Secu…
Stock Reports
NRB, inc Sees Full-Scale Public Modular Construction Orders in 4Q… Undervalued Relative to Order Intake—Hana
On the 10th, Hana Securities projected that NRB, inc.’s stock price would begin to rise as public modular housing orders pick up in earnest during the fourth quarter. The analysis suggests that, in li…
Stock Reports
LF: Korea’s Time Has Come… Target Prices for Battery Companies Raised Across the Board—Daol
As the U.S. government shows signs of restricting the use of CATL’s battery technology, expectations are growing that domestic battery companies will benefit indirectly. Daol Investment & Securities h…
Issues & Trends
“Where’s the gap in my portfolio?”… Institutions Now Seeking ‘Portfolio Doctors’
The nature of competition in the asset management industry is changing. In the past, it was common to select asset managers based on specific asset classes—such as “Which firm performs best with overs…
New York Stock
[U.S. Featured Stocks] Braze: Revenue Falls Short of Expectations, Raising Growth Concerns… Stock Price Down 19%
Shares of Braze (BRZE), a customer engagement platform provider, are plummeting as concerns about its growth prospects have come to the fore following the announcement of revenue that fell short of ma…
Disclosure Plus
Voronoi, Inc. Voluntarily Withdraws Canadian Clinical Trial for New Lung Cancer Drug ‘VRN11’… “Will Resubmit After Supplementing Data”
Voronoi, Inc.(310210)has decided to voluntarily withdraw its Canadian Clinical Trial Application (CTA) for “VRN11,” a candidate drug for non-small cell lung cancer, and to resubmit it after supplement…
Disclosure Plus
MGEN SOLUTIONS, Which Has Struggled with Losses and Frequent Fundraising, Sells Controlling Stake to Jigen Tech. CO., LTD. for 4 Billion Won
Management control of MGEN SOLUTIONS(032790)is being transferred to Jigen Tech, a waste plastic recycling company. MGEN SOLUTIONS will replace its largest shareholder and board of directors through a …
Disclosure Plus
IlyangPharmaceutical Terminates Technology Export Agreement for “Spect” in Russia… “No Financial Loss”
On the 9th, IlyangPharmaceutical(007570)announced in a regulatory filing that the contract with Russian pharmaceutical company R-Pharm for the supply of raw materials and finished products, as well as…
KOSDAQ
Eugene Technology Co., Ltd. Decides on New Facility Investment Worth 86.4 Billion
Eugene Technology Co., Ltd.(084370)announced on the 9th that it has decided to make a new facility investment of 86.4 billion won to expand its manufacturing and research facilities. The investment am…